Rayyan
Rayyan is an AI-powered SaaS platform for conducting systematic literature reviews, serving academic researchers, biopharma/HEOR teams, and institutions with screening, deduplication, PICO extraction, and Risk of Bias tools delivered via web, mobile, and API on freemium and tiered subscription plans.
- Company typePrivate
- Founded2016
- HeadquartersCambridge, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Rayyan does
Rayyan Systems, Inc. is a Cambridge, Massachusetts-based software company that builds an AI-powered platform for conducting systematic literature reviews, a workflow common in academic research, health technology assessment, and evidence-based medicine. The product covers the end-to-end review pipeline — reference import and organization, collaborative screening, AI-assisted relevance prediction, deduplication of up to 200,000 references, PICO extraction, structured data extraction, Risk of Bias assessment, and PRISMA flow diagram generation — and is accessible via web, native iOS and Android apps, and a REST API with MCP server support on the Enterprise tier.
The company's technology stack combines classical systematic review tooling with AI capabilities delivered through a module called ResearchPilot, which offers five modes (AI Reviewer, AI Analyzer, Chat with Your Data, Auto Extraction, Help Center Mode) and is gated to Business and Enterprise customers. The platform is built around a freemium-to-enterprise GTM: a permanent free tier with 3 active reviews acquires individual researchers, followed by Essential ($8.33/month quarterly) and Advanced ($13.33/month quarterly) self-serve paid tiers, then Business and Enterprise tiers requiring a 5-seat minimum with custom pricing, purchase-order and bank-transfer billing, SSO/SAML, and dedicated support. Distribution is hybrid, combining self-serve web and mobile acquisition with an enterprise sales motion supplemented by conferences, content marketing, and a YouTube/community ecosystem.
Rayyan claims 1 million+ researchers across 20,000+ institutions in 190+ countries and 3 million+ systematic reviews conducted on the platform, supported by compliance certifications including SOC 2 Type 2, ISO 27001, HIPAA, GDPR, CCPA, and WCAG 2.2 AA. The company is privately held, founded in 2016, and operates with 11–50 employees.
Rayyan firmographics
Firmographics- Name
- Rayyan
- Legal name
- Rayyan Systems, Inc.
- Website
- https://rayyan.ai
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rayyan is an AI-powered SaaS platform for conducting systematic literature reviews, serving academic researchers, biopharma/HEOR teams, and institutions with screening, deduplication, PICO extraction, and Risk of Bias tools delivered via web, mobile, and API on freemium and tiered subscription plans.
- Ownership category
- akta.pro rank
Rayyan industry classification
Industry- Product category
- Research Management Software
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Social Sciences and Humanities (54172)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
- akta.pro secondary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
Keywords
Where Rayyan is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Rayyan business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription Plans: Tiered subscription model with Free, Essential, Advanced, Business/Academic, and Enterprise tiers. Free plan provides basic access with limited features. Paid plans unlock premium AI features, increased reviewer limits, and team management capabilities. Annual billing offers up to 40% savings compared to quarterly.
- Per-Seat Licensing: Paid plans priced per seat (Essential and Advanced tiers for individuals/small teams). Business and Enterprise plans require minimum 5 licenses with custom pricing. Seats can be reassigned as team composition changes.
- Institutional Subscriptions: Custom pricing for Business/Academic and Enterprise tiers targeting research departments and institutions. Accepts Purchase Orders and offers bank transfers for institutional subscriptions. Minimum 5 license requirement for Business plan.
- API Access: API access provided as a feature in Enterprise tier, enabling integrations with external systems and workflows
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free forever plan for individual researchers getting started with systematic reviews |
| Subscription | Quarterly | Essential AI-powered tools for PhD students and postdocs |
| Subscription | Quarterly | Advanced AI-powered tools for serious professional researchers |
| Subscription | Annual | Full platform with ResearchPilot™ AI for research departments and institutions |
| Subscription | Annual | Unlimited scale with full governance and dedicated support for large institutions |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Rayyan product offering
Product offeringCore offering
Rayyan is an AI-powered systematic literature review platform delivered as a tiered SaaS subscription. It enables researchers and institutions to import references, collaborate on screening, deduplicate large reference libraries, extract structured study data, and generate PRISMA-compliant reports. The platform supports the full systematic review workflow from import through reporting, including AI-assisted screening, PICO framework extraction, Risk of Bias assessment, mobile offline screening, and an AI module (ResearchPilot™) for search, screening, and extraction.
Product overview
Rayyan is an AI-powered systematic review and literature review platform offered as a unified SaaS product with tiered subscription plans (Free, Essential, Advanced, Business/Academic, Enterprise). The core platform provides import and organization of references, collaborative screening, deduplication, and PRISMA reporting. The product portfolio includes add-on modules: ResearchPilot™ (AI search, screening, and extraction for institutions with 5 AI modes), Risk Of Bias assessment tool, Workbench for workflow management, Mobile App for iOS/Android, Data Extraction for structured data capture, Systematic Auto Resolver for duplicate removal, PICO Framework for study evaluation, API Access for enterprise integration, and Sampling for randomized subset management. The platform is accessible via web interface, mobile apps, and API, with AI features available across tiers.
Differentiator
Problem solved
Functional benefit
Products and services
- Rayyan Systematic Review Platform AI-powered systematic literature review SaaS platform that enables import and organization of references, collaborative screening, AI-assisted deduplication, structured data extraction, PICO framework extraction, Risk of Bias assessment, and auto-generated PRISMA flow diagram reporting. Sold via tiered subscriptions (Free, Essential, Advanced, Business/Academic, Enterprise) for individual researchers, research departments, institutions, and biopharma customers.
- ResearchPilot™ AI module for institutional customers offering five specialized modes: AI Reviewer (automated screening with reasoning notes), AI Analyzer (criteria-based evaluation with justification), Chat with Your Data (Q&A across the dataset), Auto Extraction (structured data extraction from PDFs), and Help Center Mode (contextual in-product support). Available on Business/Academic and Enterprise subscription tiers.
- Rayyan Mobile App Native mobile application for iOS and Android enabling systematic review screening on the go or offline, with swipe gestures to include/exclude studies, double-tap custom actions, auto-scroll, and offline work capability. Distributed through the Apple App Store (ryn.ai/ios) and Google Play (ryn.ai/android).
Quantifiable outcome
- Up to 90% time savings on systematic review screening tasks
- +3 more outcomes
Companies that use Rayyan
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Rayyan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability10 records
Feature9 records
Rayyan partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Rayyan competitors and assessment
Company assessmentDirect peers
- Covidence: Covidence is a widely adopted SaaS platform purpose-built for systematic review screening, data extraction, and PRISMA reporting, serving academic researchers, Cochrane-style evidence syntheses, and guideline developers. It is the most direct competitor to Rayyan's core screening workflow.
- DistillerSR (Evidence Partners): DistillerSR is an AI-enabled systematic review platform used by regulatory-grade health technology assessment (HTA) teams, government agencies, and pharma HEOR groups. Competes head-to-head with Rayyan in the enterprise / regulated evidence synthesis segment.
- EPPI-Reviewer: EPPI-Reviewer is an academic systematic review platform developed at UCL for evidence synthesis, including text mining and machine-learning assisted screening. Comparable to Rayyan for academic and Cochrane-adjacent users.
- JBI SUMARI: JBI SUMARI is the Joanna Briggs Institute's systematic review software for evidence-based healthcare, supporting JBI/Meta-Analysis-style reviews. Directly comparable in workflow to Rayyan for nursing, allied health, and clinical systematic reviews.
Emerging players
- Elicit: Elicit is an AI research assistant that uses LLMs to search, summarize, and extract data from academic papers. Overlaps with Rayyan's ResearchPilot™ on AI screening and data extraction but competes more broadly with the full literature review workflow.
- Nested Knowledge: Nested Knowledge is a SaaS platform for systematic literature reviews and evidence mapping with built-in PRISMA reporting and AI-assisted extraction. Direct overlap with Rayyan in pharma/medical device evidence synthesis.
- Consensus: Consensus is an AI-powered search engine for scientific research that surfaces synthesized answers from peer-reviewed literature. Adjacent competitor to Rayyan for researchers who use it as an alternative starting point to formal systematic reviews.
- Scite: Scite uses AI to classify how scientific papers cite each other and offers Smart Citations for evidence-based research. Overlaps with Rayyan's screening/extraction value prop for academic and policy researchers.
Broad incumbents
- Clarivate (Web of Science): Clarivate owns Web of Science, Derwent, and Cortellis, serving academic and life-science research organizations globally. A broad incumbent whose analytics and discovery tools increasingly overlap with Rayyan's workflow, particularly for institutional customers.
- Elsevier (Embase, Scopus): Elsevier operates Scopus, Embase, ScienceDirect, and tools such as Reaxys that support systematic literature searches and evidence synthesis. A broad incumbent that competes indirectly by integrating discovery and review-adjacent workflows for institutional buyers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Rayyan social profiles
Digital presenceRayyan compliance and trust
Trust signalCompliance7 records
Rayyan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rayyan leadership team
Management profileNumber of profiles
Profiles2 records
Rayyan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rayyan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rayyan
What does Rayyan do?
Rayyan is an AI-powered systematic literature review platform delivered as a tiered SaaS subscription. It enables researchers and institutions to import references, collaborate on screening, deduplicate large reference libraries, extract structured study data, and generate PRISMA-compliant reports. The platform supports the full systematic review workflow from import through reporting, including AI-assisted screening, PICO framework extraction, Risk of Bias assessment, mobile offline screening, and an AI module (ResearchPilot™) for search, screening, and extraction.
Is Rayyan a public or private company?
Rayyan is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Rayyan founded?
Rayyan was founded in 2016. It employs 11 to 50 people.
Where is Rayyan based?
Rayyan is headquartered in Cambridge, United States, in the North America region.
How does Rayyan make money?
Four revenue lines are on record. Subscription Plans are the primary driver. The others are per-Seat Licensing, institutional Subscriptions and API Access.
Who are Rayyan's main competitors?
Direct peers on record are Covidence, DistillerSR (Evidence Partners), EPPI-Reviewer and JBI SUMARI. Emerging players are Elicit, Nested Knowledge, Consensus and Scite. Broad incumbents are Clarivate (Web of Science) and Elsevier (Embase, Scopus).
Does Rayyan have an API?
Yes. Rayyan offers API Access as a feature available on Enterprise plans. The API allows users to extend Rayyan beyond the interface and integrate with external systems. Available on Enterprise tier with SSO/SAML support. MCP (Model Context Protocol) Server is also available on Enterprise plan. Developer documentation is at www.rayyan.ai/api-access.
What industry is Rayyan in?
Rayyan's product category is Research Management Software. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 5417 and its SIC code is 7370.